
Product Pipeline

Product Pipeline - Human
IRP has completed the screening of four drug-resistant bacteria and their combinations, including Clostridium difficile, Campylobacter, ESBL + resistant bacteria, and Staphylococcus aureus.
IRP004CD
IRP004CB
Human being
Clostridium difficile
Pseudomembranous enteritis is an acute mucosal necrotic inflammation that mainly occurs in the colon and is covered with a pseudomembrane. It has been confirmed to be caused by the toxin of Clostridium difficile. Severe illness can be fatal. It has been listed as a serious threat by the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).
Human being
Campylobacter
Campylobacter is one of the four global causes of diarrhea. The bacterium is the most common cause of gastroenteritis from a bacterial perspective in the world. Campylobacter infections are usually mild, but can be fatal to very young children, the elderly, and immunosuppressed people.
Phermatix
Human being
Extended Spectrum
Beta-Lactamases
Because of its resistance to major antibiotics, there are fewer types of antibiotics currently available. ESBL + drug-resistant bacteria cause serious harm to human beings. The World Health Organization (WHO) and the US Centers for Disease Surveillance and Prevention (CDC) have classified ESBL + drug-resistant bacteria as ‘emergency’.
IRP004SA
Human being
Staphylococcus aureus
It is an important pathogenic bacteria in humans and a representative of Gram-negative bacteria, which can cause many serious infections. The United States Centers for Disease Control (CDC) reports that infections caused by Staphylococcus aureus account for the second place, only for E. coli.
Prof. Dena Lyras
Prof. Jian Li
Prof. Jian Li
Prof. Jian Li ;
Dr. Darren Trott
Product
Target Species
Diseases
Incidence
Collaborator
* List of commonly used antibacterial products for human use
Me much better Related product development process and progress
Drug Name
Indications
Potential market
size
(by 2030)
IP
R&D process and current progress
Target
Compound
Experimental
Verification
Formulation
Small Batch
Production
TGA
Filing
Market
Mass
Production
Australian
Market
FDA
Filing
American
market
Chinese market
Drug
declarations
Cross-border
e-commerce sales
Note
UPPLUS-A
Capsule
Respiratory
health
$26.5 billion
Acquired
UPPLUS
KBD Spray
Respiratory
health
$26.5 billion
Acquired
Australian Market and Cross-border e-commerce sales in the Chinese market have been carried out. The U.S. market is already legally accessible, and China's long-term market is yet to be developed.
UPPLUS-G
Brain health
$230.1 billion
Available
UPPLUS-B
Weight
Control
$825 billion
Available
UPPLUS-F
Enhancing
Immunity for
against cancers
$581.25 billion
Available
UPPLUS-N
Insomnia
$1.87 billion
Available
UPPLUS-E
Osteoporosis
$22,947 million
Available
UPPLUS-L
CVD and
hypercholester
olemia
$34 billion
Available
UPPLUS-T
UPPLUS-BC
Anti-ageing
$119.6 billion
Available
Breast
Cancer
$47.7 billion
Available
UPPLUS-LC
Lung Cancer
$48 billion
Available
UPPLUS-CC
Colorectal
Cancer
$39.83 billion
Available
UPPLUS-PC
Prostate
Cancer
$30 billion
Available
UPPLUS-SC
Skin Cancer
(Melanoma)
$16.94 billion
Available

Product Pipeline - Animal
Gut-C: Feed Additive for Chicken
Gut-C, in the form of feed additive premix, can inhibit Coccidiosis, prevent/treat Necrotic Enteritis, reduce the amount of Campylobacter, and enhance FCR.
Product
Target Species
Diseases
Incidence
Collaborator
Prof. Chuck;
Prof. Rob.Moore
Prof.Chuck;
Prof.Pat Blackall
Prof. Peter Grover;
Greg.
Gut-C
Chicken
Necrotic Enteritis
Chicken
Campylobacteriosis
Chicken
Coccidiosis
Necrotic Enteritis (NE) is an intestinal gut infection found in food-producing animals such as poultry.
Campylobacteriosis is a gastrointestinal disease. It can spread widely through contact. EU and the US have highlighted the plight of CB in chicken and called for control before processing.
Coccidiosis is caused by parasite Eimeria. It can reduce FCR by affecting weight gain. 95.61% of economic loss in broiler industry is attributed to this diseases.
Gut-P: Feed Additive for Pigs
Gut-P can prevent and treat Ileitis in pigs caused by Lawsonia.
Product
Target Species
Diseases
Incidence
Collaborator
Gut-P
Pig
Lawsonia
Ileitis is the No.1 health problem in growing pigs. Nearly 42% of grow/finish operations reported clinical ileitis and nearly 94% of herds found to have subclinical ileitis. The mortality rate can be as high as 50%.
Dr. Ryan Saltzman
Gut-X: Veterinary medicine for cattle
Gut-X is used to treat cattle mastitis.
Product
Target Species
Diseases
Incidence
Collaborator
Gut-X
Cattle
Mastitis
Mastitis is the inflammation of the mammary gland and udder tissue, and is a major endemic disease of dairy cattle. It usually occurs as an immune response to bacterial invasion of the teat canal by variety of bacterial sources present on the farm, and can also occur because of chemical, mechanical, or thermal injury to the cow's udder.
Dr. Darren Troot
Product Pipeline - mRNA Vaccine for Animal Use
Product
Target Species
Diseases
Incidence
Collaborator
ASF
Porcine
circovirus
Porcine
Parvovirus
Pig
Pig
Pig
Bovine viral
diarrhea
Cattle
Canine core
vaccines
Dog
Non-core
vaccines
Dog/Cat
African swine fever
Has been around for about a century, bringing huge losses and threats to the world's pig industry.
Prof. Colin Pouton
Porcine circovirus
One of the three major diseases that have been plaguing pig industry in China.
Porcine Parvovirus
Mainly manifested in the infection and death of embryos and fetuses, especially the stillbirth, malformation and mummified fetuses of first-born sows, but the sows themselves have no obvious symptoms.
Bovine viral diarrhea
One of the major cattle diseases worldwide. Like other viral diseases, BVD cannot be treated.
CDV,CAV,CPV-2
CDV,CAV,CPV-2
Leptospirosis
Is a zoonotic disease in the tropics and subtropics. China is one of the countries most affected by leptospirosis, and also the country with the most abundant leptospirosis serotypes in the world.